| 2BC3 | B: | T7-TAGGED FULL-LENGTH STREPTAVIDIN |
| 2QCB | A: | T7-TAGGED FULL-LENGTH STREPTAVIDIN COMPLEXED WITH RUTHENIUM LIGAND |
| 2WPU | A: | CHAPERONED RUTHENIUM METALLODRUGS THAT RECOGNIZE TELOMERIC DNA |
| 2Y3E | A:; B: | TRAPTAVIDIN, APO-FORM |
| 2Y3F | A: | TRAPTAVIDIN, BIOTIN BOUND FORM |
| 3MG5 | A:; B:; C:; D: | CORE-STREPTAVIDIN MUTANT F130L IN COMPLEX WITH BIOTIN |
| 3PK2 | A: | ARTIFICIAL TRANSFER HYDROGENASES FOR THE ENANTIOSELECTIVE REDUCTION OF CYCLIC IMINES |
| 3RDM | A: | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH BIOTIN/PEG |
| 3RDO | A:12-135 | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH BIOTIN |
| 3RDQ | A:12-134 | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH DESTHIOBIOTIN |
| 3RDS | A: | CRYSTAL STRUCTURE OF THE REFOLDED R7-2 STREPTAVIDIN |
| 3RDU | A: | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH PEG |
| 3RDX | A:; B: | CRYSTAL STRUCTURE OF LIGAND-FREE R7-2 STREPTAVIDIN |
| 3RE5 | A: | CRYSTAL STRUCTURE OF R4-6 STREPTAVIDIN |
| 3RE6 | A: | CRYSTAL STRUCTURE OF R4-6 STREPTAVIDIN |
| 3T6F | A:; B: | BIOTIN COMPLEX OF Y54F CORE STREPTAVIDIN |
| 3T6L | A: | Y54F MUTANT OF CORE STREPTAVIDIN |
| 4BX5 | A:; C: | CIS-DIVALENT STREPTAVIDIN |
| 4BX6 | A:; B:; C:; D: | TRANS-DIVALENT STREPTAVIDIN |
| 4BX7 | A:; B: | TRANS-DIVALENT STREPTAVIDIN BOUND TO BIOTIN-4-FLUORESCEIN |
| 4DNE | A:; B: | CRYSTAL STRUCTURE OF A TRIPLE-MUTANT OF STREPTAVIDIN IN COMPLEX WITH DESTHIOBIOTIN |
| 4EKV | A: | STREPTAVIDIN 8-AA-LOOP H127C MUTEIN WITH REVERSIBLE BIOTIN BINDING |
| 4GD9 | A:; B:; C:; D: | CIRCULAR PERMUTED STREPTAVIDIN N49/G48 |
| 4GDA | A:; B: | CIRCULAR PERMUTED STREPTAVIDIN A50/N49 |
| 4GJS | A:; B: | STREPTAVIDIN-K121H |
| 4GJV | A: | STREPTAVIDIN-S112H |
| 4JNJ | A:; B:; C:; D: | STRUCTURE BASED ENGINEERING OF STREPTAVIDIN MONOMER WITH A REDUCED BIOTIN DISSOCIATION RATE |
)
)